These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1483493)

  • 41. Effects of beta 1-selective and nonselective beta-adrenoceptor blockade during exercise conditioning in healthy adults.
    McLeod AA; Kraus WE; Williams RS
    Am J Cardiol; 1984 Jun; 53(11):1656-61. PubMed ID: 6375340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.
    Conway FJ; Fitzgerald JD; McAinsh J; Rowlands DJ; Simpson WT
    Br J Clin Pharmacol; 1976 Apr; 3(2):267-72. PubMed ID: 973955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Observations on the mechanism underlying the differences in exercise and isoprenaline tachycardia after cardioselective and non-selective beta-adrenoceptor antagonists.
    McGibney D; Singleton W; Silke B; Taylor SH
    Br J Clin Pharmacol; 1983 Jan; 15(1):15-9. PubMed ID: 6849739
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetic and pharmacodynamic interaction of single doses of valsartan and atenolol.
    Czendlik CH; Sioufi A; Preiswerk G; Howald H
    Eur J Clin Pharmacol; 1997; 52(6):451-9. PubMed ID: 9342580
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of captopril, propranolol, and verapamil on arterial pulse wave velocity and other cardiovascular parameters in healthy volunteers.
    Kähönen M; Ylitalo R; Kööbi T; Turjanmaa V; Ylitalo P
    Int J Clin Pharmacol Ther; 1998 Sep; 36(9):483-9. PubMed ID: 9760009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for cardiac beta 2-adrenoceptors in man.
    Brown JE; McLeod AA; Shand DG
    Clin Pharmacol Ther; 1983 Apr; 33(4):424-8. PubMed ID: 6299641
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The distribution of propranolol, pindolol and atenolol between human erythrocytes and plasma.
    Taylor EA; Turner P
    Br J Clin Pharmacol; 1981 Oct; 12(4):543-8. PubMed ID: 7295488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine.
    Kirch W; Spahn H; Köhler H; Ohnhaus EE; Mutschler E
    Klin Wochenschr; 1982 Nov; 60(22):1401-7. PubMed ID: 7176462
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of digoxin, propranolol, and verapamil on exercise in patients with chronic isolated atrial fibrillation.
    Matsuda M; Matsuda Y; Yamagishi T; Takahashi T; Haraguchi M; Tada T; Kusukawa R
    Cardiovasc Res; 1991 Jun; 25(6):453-7. PubMed ID: 1889058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differentiation of hemodynamic, humoral and metabolic responses to beta 1- and beta 2-adrenergic stimulation in man using atenolol and propranolol.
    McLeod AA; Brown JE; Kuhn C; Kitchell BB; Sedor FA; Williams RS; Shand DG
    Circulation; 1983 May; 67(5):1076-84. PubMed ID: 6299612
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The interaction of cigarette smoking and beta-adrenoceptor blockade.
    Fox K; Deanfield J; Krikler S; Ribeiro P; Wright C
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):92S-93S. PubMed ID: 6146345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential interactions between exercise and drug therapy.
    Lenz TL; Lenz NJ; Faulkner MA
    Sports Med; 2004; 34(5):293-306. PubMed ID: 15107008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In support of cardiac chronotropic beta 2 adrenoceptors.
    Brown JE; McLeod AA; Shand DG
    Am J Cardiol; 1986 Apr; 57(12):11F-16F. PubMed ID: 3010692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of beta-adrenoceptor agonists and antagonists on heart-rate variability in normal subjects assessed using summary statistics and nonlinear procedures.
    Silke B; Guy S; Riddell JG
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):817-23. PubMed ID: 9436823
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of the beta-adrenoceptor antagonists atenolol and propranolol on human whole saliva flow rate and composition.
    Nederfors T; Dahlöf C
    Arch Oral Biol; 1992; 37(7):579-84. PubMed ID: 1280091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man.
    Wellstein A; Palm D; Pitschner HF; Belz GG
    Eur J Clin Pharmacol; 1985; 29(2):131-47. PubMed ID: 3000793
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transport of beta-blockers and calcium antagonists by diffusion in cat myocardium.
    Haunsø S; Sejrsen P; Svendsen JH
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):357-64. PubMed ID: 1711595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular and pharmacokinetic consequences of combined administration of verapamil and propranolol in dogs.
    Hamann SR; Kaltenborn KE; Vore M; Tan TG; McAllister RG
    Am J Cardiol; 1985 Jul; 56(1):147-56. PubMed ID: 4014021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of selective and nonselective beta-adrenoceptor blockade on thermoregulation during prolonged exercise in heat.
    Gordon NF
    Am J Cardiol; 1985 Apr; 55(10):74D-78D. PubMed ID: 3993552
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of exercise testing, training and beta blockade on serum potassium in normal subjects.
    Fletcher GF; Fletcher BJ; Sweeney ME
    Am J Cardiol; 1990 May; 65(18):1242-5. PubMed ID: 2337035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.